Two Years of Ocrelizumab Treatment in Black and Hispanic People with Multiple Sclerosis in CHIMES: A Single-Arm Clinical Trial.

Amezcua L, Reder AT, Bernitsas E, Monson NL, Vartanian T, Wu GF, Saleh M, Okai A, Obeidat AZ, Sokhi D, et al.

Ann Neurol. 2026 Jul 30. PMID: 42530333. Abstract